Works matching AU Hatzis, Christos


Results: 59
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Increased epigenetic age in normal breast tissue from luminal breast cancer patients.

    Published in:
    Clinical Epigenetics, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13148-018-0534-8
    By:
    • Hofstatter, Erin W.;
    • Horvath, Steve;
    • Dalela, Disha;
    • Gupta, Piyush;
    • Chagpar, Anees B.;
    • Wali, Vikram B.;
    • Bossuyt, Veerle;
    • Storniolo, Anna Maria;
    • Hatzis, Christos;
    • Patwardhan, Gauri;
    • Von Wahlde, Marie-Kristin;
    • Butler, Meghan;
    • Epstein, Lianne;
    • Stavris, Karen;
    • Sturrock, Tracy;
    • Au, Alexander;
    • Kwei, Stephanie;
    • Pusztai, Lajos
    Publication type:
    Article
    18
    19
    20
    21

    Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2015, v. 154, n. 3, p. 533, doi. 10.1007/s10549-015-3631-9
    By:
    • Sanft, Tara;
    • Aktas, Bilge;
    • Schroeder, Brock;
    • Bossuyt, Veerle;
    • DiGiovanna, Michael;
    • Abu-Khalaf, Maysa;
    • Chung, Gina;
    • Silber, Andrea;
    • Hofstatter, Erin;
    • Mougalian, Sarah;
    • Epstein, Lianne;
    • Hatzis, Christos;
    • Schnabel, Cathy;
    • Pusztai, Lajos
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Atherogenic risk factors among preschool children in Crete, Greece.

    Published in:
    Indian Journal of Endocrinology & Metabolism, 2012, v. 16, n. 5, p. 809, doi. 10.4103/2230-8210.100683
    By:
    • Hatzis, Christos M.;
    • Papandreou, Christopher;
    • Vardavas, Constantine I.;
    • Athanasopoulos, Dimitris;
    • Balomenaki, Euaggelia;
    • Kafatos, Anthony G.
    Publication type:
    Article
    28
    29
    30

    A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer.

    Published in:
    JAMA: Journal of the American Medical Association, 2011, v. 305, n. 18, p. 1873, doi. 10.1001/jama.2011.593
    By:
    • Hatzis, Christos;
    • Pusztai, Lajos;
    • Valero, Vicente;
    • Booser, Daniel J.;
    • Esserman, Laura;
    • Lluch, Ana;
    • Vidaurre, Tatiana;
    • Holmes, Frankie;
    • Souchon, Eduardo;
    • Hongkun Wang;
    • Martin, Miguel;
    • Cotrina, José;
    • Gomez, Henry;
    • Hubbard, Rebekah;
    • Chacón, J. Ignacio;
    • Ferrer-Lozano, Jaime;
    • Dyer, Richard;
    • Buxton, Meredith;
    • Yun Gong;
    • Yun Wu
    Publication type:
    Article
    31
    32

    Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.

    Published in:
    Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00879-x
    By:
    • Li, Xiaotong;
    • Kumar, Sushant;
    • Harmanci, Arif;
    • Li, Shantao;
    • Kitchen, Robert R.;
    • Zhang, Yan;
    • Wali, Vikram B.;
    • Reddy, Sangeetha M.;
    • Woodward, Wendy A.;
    • Reuben, James M.;
    • Rozowsky, Joel;
    • Hatzis, Christos;
    • Ueno, Naoto T.;
    • Krishnamurthy, Savitri;
    • Pusztai, Lajos;
    • Gerstein, Mark
    Publication type:
    Article
    33

    Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 11, p. 1817, doi. 10.1002/cncr.29254
    By:
    • Abu‐Khalaf, Maysa M.;
    • Baumgart, Megan A.;
    • Gettinger, Scott N.;
    • Doddamane, Indukala;
    • Tuck, David P.;
    • Hou, Shihe;
    • Chen, Nianhang;
    • Sullivan, Catherine;
    • Lezon‐Geyda, Kimberly;
    • Zelterman, Daniel;
    • Hatzis, Christos;
    • Deshpande, Hari;
    • Digiovanna, Michael P.;
    • Azodi, Masoud;
    • Schwartz, Peter E.;
    • Harris, Lyndsay N.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    First international TNBC conference meeting report.

    Published in:
    Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 407, doi. 10.1007/s10549-018-4692-3
    By:
    • Rida, Padmashree;
    • Ogden, Angela;
    • Ellis, Ian O.;
    • Varga, Zsuzsanna;
    • Wolff, Antonio C.;
    • Traina, Tiffany A.;
    • Hatzis, Christos;
    • Palmer, Julie R.;
    • Ambrosone, Christine B.;
    • Lehmann, Brian D.;
    • Nanda, Rita;
    • Montgomery Rice, Valerie;
    • Brawley, Otis W.;
    • Torres, Mylin A.;
    • Rakha, Emad;
    • Aneja, Ritu
    Publication type:
    Article
    49

    Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2018, v. 169, n. 2, p. 333, doi. 10.1007/s10549-017-4653-2
    By:
    • Foldi, Julia;
    • Mougalian, Sarah;
    • Silber, Andrea;
    • Lannin, Donald;
    • Killelea, Brigid;
    • Chagpar, Anees;
    • Horowitz, Nina;
    • Frederick, Courtney;
    • Rispoli, Lawrence;
    • Burrello, Trisha;
    • Abu-Khalaf, Maysa;
    • Sabbath, Kert;
    • Sanft, Tara;
    • Brandt, Debra S.;
    • Hofstatter, Erin W.;
    • Hatzis, Christos;
    • DiGiovanna, Michael P.;
    • Pusztai, Lajos
    Publication type:
    Article
    50